Online Only Articles

Variable global distribution of cell-of-origin from the ROBUST phase III study in diffuse large B-cell lymphoma

Division of Hematology, Mayo Clinic, Rochester, MN, USA
Division of Hematology, Città della Salute e della Scienza Hospital and University, Torino, Italy
Division of Hematology, Mayo Clinic, Rochester, MN, USA
Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada
Division of Medical Oncology A, National Cancer Institute, Aviano, Italy
Division of Hematology, Mayo Clinic, Rochester, MN, USA;Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada
Celgene Corporation, Summit, NJ; USA
Celgene Corporation, Summit, NJ; USA
Celgene Corporation, Summit, NJ; USA
Celgene Corporation, Summit, NJ; USA
Celgene Corporation, Summit, NJ; USA
Division of Hematology, Città della Salute e della Scienza Hospital and University, Torino, Italy
Vol. 105 No. 2 (2020): February, 2020 https://doi.org/10.3324/haematol.2019.220475